The Food and Drug Administration (FDA) recently announced that it had identified “significant data integrity and study conduct concerns” ...

The U.S. Food and Drug Administration (FDA) on Monday cleared the amendment to Lantern Pharma Inc.’s (NASDAQ:LTRN) Investigational New Drug (IND) application for the Phase 1b/2 trial of LP-184 in a ...

Ireland’s Health and Safety Executive has criticised a new report revealing the country’s shocking last place in Western Europe for new oncology drug access.

IND application submission on track for Q2 2025: MBX 4291, a GLP-1/GIP co-agonist prodrug, is being developed as a once-monthly treatment for obesity. The Company expects to submit an IND application ...

Advanced Preparation for New Drug Application ~ SAN DIEGO, CA / ACCESS Newswire / May 12, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical ...

A photograph with a notorious figure may be behind the Trump administration's refusal to grant a top international politician ...

ECONOMYNEXT – New active credit cards in Sri Lanka increased by 11,881 in March this year, the central bank data showed, amid ...

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of ...

The legalization of adult-use cannabis across numerous U.S. states was driven by more than economic or regulatory motivations ...

The United States and China have agreed to suspend the 125 percent 'reciprocal' tariffs imposed on each other for 90 days, ...

Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

Zeeshan Saeed, CEO of Quantum BioPharma added, "We are excited about potential of Lucid-21-302 as a new first-in-class treatment for Multiple Sclerosis. By completing these toxicity studies, we are ...